首页 | 本学科首页   官方微博 | 高级检索  
检索        

桂枝茯苓胶囊主要效应成分在比格犬体内的药代动力学
引用本文:朱克近,孙晓萍,常秀娟,秦建平,吕新勇,王振中,萧伟.桂枝茯苓胶囊主要效应成分在比格犬体内的药代动力学[J].中国中药杂志,2011,36(8):1015-1018.
作者姓名:朱克近  孙晓萍  常秀娟  秦建平  吕新勇  王振中  萧伟
作者单位:江苏康缘药业股份有限公司,江苏,连云港,222001;中药制药过程新技术国家重点实验室,江苏,连云港,222001;江苏省企业院士工作室,江苏,连云港,222001
基金项目:国家重大新药创制专项(2009ZX09504-004)
摘    要:目的:研究桂枝茯苓胶囊中主要成分芍药苷、芍药内酯苷、苦杏仁苷在比格犬体内的药代动力学特征.方法:比格犬口服给予桂枝茯苓胶囊0.044 8,0.179 2 g·kg-1后,前肢静脉收集血浆样本,经固相萃取小柱富集后,HPLC-MS/MS检测血药浓度,DAS 2.0软件计算药代动力学参数.结果:芍药苷、芍药内酯苷、苦杏仁苷体内检测定量限分别为0.25,2.64,0.04μg·L-1,不同剂量下芍药苷t1/2分别为4.33,3.62 h;芍药内酯苷t1/2分别为6.16,5.91 h,苦杏仁苷t1/2分别为2.43,1.32 h;各成分体内AUC0-t与剂量有较好相关性.结论:芍药苷、芍药内酯苷、苦杏仁苷在体内均有较高暴露量,可用二室模型来描述.

关 键 词:芍药苷  芍药内酯苷  苦杏仁苷  桂枝茯苓胶囊  药代动力学
收稿时间:2011/3/16 0:00:00

Pharmacokinetics of Guizhi Fuling capsule in beagle dogs
ZHU Kejin,SUN Xiaoping,CHANG Xiujuan,QIN Jianping,LV Xinyong,WANG Zhenzhong and XIAO Wei.Pharmacokinetics of Guizhi Fuling capsule in beagle dogs[J].China Journal of Chinese Materia Medica,2011,36(8):1015-1018.
Authors:ZHU Kejin  SUN Xiaoping  CHANG Xiujuan  QIN Jianping  LV Xinyong  WANG Zhenzhong and XIAO Wei
Institution:Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China;Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China;Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China;Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China;Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China;Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China;Jangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang 222001, China;State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222001, China;Enterprises Academician Workstations in Jiangsu Province, Lianyungang 222001, China
Abstract:Objective: To investigate pharmacokinetic parameters of peoniflorin,albiflorin and amygdaloside after administration of Guizhi Fuling capsule in beagle dogs.Method: Plasma was collected from forelimb vein of Beagle dogs after oral administration of GuizhiFuling capsule.HPLC-MS/MS method was used to determine the concentrations of constituents in plasma.The pharmacokinetic parameters were analyzed by program DAS 2.0.Result: The limit of quantitation of peoniflorin,albiflorin and amygdaloside were 0.25,2.64,0...
Keywords:peoniflorin  albiflorin  amygdaloside  Guizhi Fuling capsule  phamacokinetics
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号